Combined silencing of VEGF-A and angiopoietin-2, a more effective way to inhibit the Ishikawa endometrial cancer cell line

BACKGROUND: Angiogenesis is critical for the growth and metastasis of solid tumors and is, therefore, an important therapeutic target. Despite the great research advances in tumor therapies targeting vascular endothelial growth factor (VEGF), drug resistance frequently occurs, and further strategies...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Onco Targets Ther
Autori principali: Xu, Xiaofeng, Yan, Yuhua, Xun, Qingying, Shi, Jiayu, Kong, Xiangyi, Wu, Jun, Zhou, Huaijun
Natura: Artigo
Lingua:Inglês
Pubblicazione: Dove Medical Press 2019
Soggetti:
Original Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6388957/
https://ncbi.nlm.nih.gov/pubmed/30863089
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S194064
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi